
Evox Therapeutics
Engineering exosomes to deliver protein and nucleic acid-based therapeutics to treat life-threatening rare diseases.
Enterprise value
$365—548m
Company register number
Recent deals
Authorizing premium user...
Engineering exosomes to deliver protein and nucleic acid-based therapeutics to treat life-threatening rare diseases.